Dark

TLSA
Tiziana Life Sciences Ltd. Common Shares
stock NASDAQ

At Close

Sep 5, 2025 3:59:30 PM EDT

1.66USD+5.063%(+0.08)393,679

0.00Bid 0.00Ask 0.00Spread

Pre-market

Sep 5, 2025 9:28:30 AM EDT

1.74USD+10.127%(+0.16)10,349

After-hours

Sep 5, 2025 4:03:30 PM EDT

1.66USD0.000%(0.00)1,500

OverviewOptionsHistoricalExchangesShortsNews

Jan 26, 2022

07:00AM EST Tiziana Life Sciences to participate in a Fireside Chat At the B. GlobeNewswire Inc

Jan 24, 2022

11:24AM EST Tiziana Life Sciences Ltd. To Implement Stock Repurchase Program GlobeNewswire Inc

Jan 13, 2022

07:00AM EST Tiziana Life Sciences (Nasdaq: TLSA) (Tiziana), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announced that Dr. Thomas Adams passed away on January 9, 2022. He served as a member of Tiziana Life Sciences Board of Directors since February 2021. GlobeNewswire Inc

Jan 11, 2022

09:23AM EST TLSA: SPMS Update; Second Patient Gains Access Benzinga

Jan 10, 2022

07:38AM EST Tiziana Enrolls Second Patient in Ongoing Intranasal Foralumab Evaluation for Secondary Progressive Multiple Sclerosis Benzinga

07:01AM EST - Clinical data from the first patient, after completing 3 out of 6 months, suggest that the treatment was well tolerated with a favorable clinical response GlobeNewswire Inc

Jan 6, 2022

04:15PM EST Tiziana Life Sciences to Participate in 2022 Biotech Showcase GlobeNewswire Inc

Oct 21, 2021

02:00AM EDT THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. GlobeNewswire Inc

Oct 20, 2021

02:00AM EDT Tiziana Life Sciences plc: PDMR Dealing GlobeNewswire Inc

Oct 19, 2021

09:29AM EDT Tiziana Life Sciences Says Court Sanctions Scheme Of Arrangement And Approves Reduction Of Capital Benzinga

09:27AM EDT Tiziana Life Sciences plc: Court Sanctions the Scheme of GlobeNewswire Inc

Oct 11, 2021

05:41AM EDT TLSA: 1H:21 Financial Update Benzinga

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 5, 2021

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Oct 1, 2021

07:56AM EDT The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO Benzinga

Sep 30, 2021

07:43AM EDT The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug Benzinga

Sep 29, 2021

08:13AM EDT The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug Benzinga

Sep 28, 2021

04:19AM EDT Tiziana Life Sciences plc: PDMR Dealing GlobeNewswire Inc

Sep 27, 2021

12:39PM EDT Tiziana Life Sciences Plc - Results of Court Meeting and General GlobeNewswire Inc

Sep 24, 2021

12:52PM EDT London, 24 September 2021 Tiziana Life Sciences plc (Tiziana, LSE: TILS, NASDAQ: TLSA), a biotechnology company a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases today announces its interim results for the six months ended 30 June 2021. GlobeNewswire Inc

Sep 20, 2021

11:51AM EDT TLSA: Partnership with Precision Benzinga

Sep 7, 2021

05:41AM EDT TLSA: Foralumab Now in CAR T Benzinga

02:00AM EDT Tiziana to HostInvestor Call to Discuss Exclusive GlobeNewswire Inc

Sep 3, 2021

Sep 2, 2021

08:20AM EDT The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab Benzinga

07:03AM EDT The following are some of the stocks making big moves in Thursday's pre-market trading (as of 6.45 A.M. EDT). RTTNews

05:50AM EDT Precision BioSciences, Tiziana Life Sciences Announced Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment Benzinga

02:25AM EDT Precision BioSciences, Tiziana Life Sciences To Evaluate Foralumab With Allogeneic CAR T Candidates For Cancer Treatment RTTNews

02:00AM EDT Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment Business Wire

02:00AM EDT Precision BioSciences and Tiziana Life Sciences Announce Exclusive GlobeNewswire Inc

Aug 31, 2021

11:19AM EDT Tiziana Life Sciences Sponsored Study Titled 'A Study of Oral Foralumab in Participants With Moderate to Severely Active Crohn's Disease' Posted To ClinicalTrials.Gov; Study Not Yet Recruiting Benzinga

11:18AM EDT Tiziana Life Sciences ClinicalTrials.gov Listing For Co.'s 'Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS,' Recruitment Status Says 'Not Yet Recruiting' Benzinga

Aug 24, 2021

08:09AM EDT The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal Benzinga

Aug 20, 2021

07:45AM EDT The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data Benzinga

02:00AM EDT Tiziana Life Sciences plc files scheme of arrangement to effect a GlobeNewswire Inc

Aug 19, 2021

10:57AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

Aug 18, 2021

05:57AM EDT The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.32 A.M. EDT). RTTNews

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

05:52AM EDT The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 5.37 A.M. EDT). RTTNews

02:00AM EDT Tiziana Announces Publication of a Peer Reviewed Article on Data GlobeNewswire Inc

Jul 21, 2021

07:52AM EDT The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay Benzinga

Jul 8, 2021

07:59AM EDT Tiziana Life Sciences plc - ADS Ex-Dividend Date Scheduled for GlobeNewswire Inc

Jul 7, 2021

11:28AM EDT TLSA: Intranasal Foralumab in COVID-19 Benzinga

Jul 2, 2021

07:59AM EDT Tiziana Life Sciences Reports Forms 20-F, F-6 Filed By Accustem Sciences With SEC Have Been Declared Effective, Enabling Completion Of In Specie Distribution, Spin Out Of Accustem Sciences Benzinga

07:58AM EDT Tiziana Life Sciences plc -Distribution Dates for GlobeNewswire Inc

Jun 30, 2021

06:47AM EDT Dr Howard Weiner, Chairman of the Tiziana Scientific Advisory GlobeNewswire Inc

Jun 25, 2021

06:15AM EDT At the Annual General Meeting of the Company held at 10.00 a.m. on 25June 2021, all of the resolutions were duly passed. GlobeNewswire Inc

Jun 23, 2021

07:35AM EDT The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway Benzinga

05:50AM EDT Tiziana Announced Collaboration Agreement with FHI Clinical to Conduct a Phase 2 Clinical Trial for Treating Hospitalized Severe COVID-19 Patients with Intranasal Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody Benzinga

03:43AM EDT Tiziana Agrees With FHI Clinical To Conduct Phase 2 Clinical Trial For COVID-19 Patients With Intranasal Foralumab RTTNews

02:00AM EDT Tiziana Enters a Collaboration Agreement with FHI Clinical to GlobeNewswire Inc

Jun 21, 2021

02:00AM EDT Tiziana Appoints Dr. Kevin Schutz as Vice-President of Regulatory GlobeNewswire Inc

Jun 17, 2021

02:00AM EDT Tiziana Responds to UK Call for Development of Innovative GlobeNewswire Inc

Jun 2, 2021

02:00AM EDT NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. GlobeNewswire Inc

May 26, 2021

06:38AM EDT Tiziana Life's Foralumab Induces Immunomodulation, Anti-Inflammatory Effects In Early-Stage Study Benzinga

02:00AM EDT Tiziana Reports Data Indicating Significant Immunomodulation GlobeNewswire Inc

May 25, 2021

07:53AM EDT The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal Benzinga

06:16AM EDT Tiziana Life Starts Testing Nasally Administered Foralumab in Multiple Sclerosis Patients Benzinga

02:00AM EDT Tiziana Life Sciences Announces Initiation of Clinical Trial in a GlobeNewswire Inc

May 7, 2021

02:00AM EDT Tiziana Life Sciences Interview to Air on Bloomberg Television U.S GlobeNewswire Inc

May 5, 2021

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

02:00AM EDT Tiziana Announces Strategic Initiative with Takanawa Japan K.K., GlobeNewswire Inc

Apr 27, 2021

02:00AM EDT Tiziana Life Sciences to participate in a Fireside Chat on 28 GlobeNewswire Inc

Apr 19, 2021

05:11AM EDT TLSA: Accustem Converging on NASDAQ Benzinga

Apr 17, 2021

06:31AM EDT TLSA: In a Tizzy About Tiziana Benzinga

Apr 13, 2021

10:55AM EDT Tiziana Life Sciences Shares See Volume; Co Granted U.S. Patent Titled 'Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia' Benzinga

08:16AM EDT The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug Benzinga

07:00AM EDT Tiziana Life Sciences plc (NASDAQ:TLSA;LSE: TILS),today announced that its former subsidiary, Accustem Sciences Limited ("Accustem"), intends to file a listing application with the Nasdaq Stock Market shortly after completion of the distribution of shares in Accustem to Tiziana Life Sciences plc shareholders. GlobeNewswire Inc

Apr 12, 2021

12:04PM EDT Zacks Investment Research Initiates Coverage On Tiziana Life Sciences with Not Rated Rating, Announces Price Target of $7.5 Benzinga

Mar 30, 2021

11:04AM EDT Tiziana To Treat Multiple Sclerosis Patient With Nasal Administration of Foralumab Benzinga

08:25AM EDT Tiziana Announces FDA Has Allowed Treatment For A Secondary Progressive Multiple Sclerosis Patient For The Nasal Administration Of Foralumab, A Fully Human Anti-CD3 Monoclonal Antibody, Under An Individual Patient Expanded Access Program Benzinga

08:06AM EDT The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings Benzinga

08:00AM EDT Tiziana Announces the FDA Has Allowed Treatment for a Secondary GlobeNewswire Inc

07:36AM EDT Tiziana Life Sciences plc: Accustem Update GlobeNewswire Inc

06:46AM EDT Tiziana Life Prepares Further Development Of Foralumab In COVID-19 Patients Benzinga

02:00AM EDT Tiziana Plans Phase 2 Clinical Study in Moderate to Severe GlobeNewswire Inc

Mar 29, 2021

08:31AM EDT Updated - Gabriele Cerrone, Chairman of Tiziana Life Sciences to GlobeNewswire Inc

02:00AM EDT Tiziana Life Sciences plc("Tiziana" or the "Company") GlobeNewswire Inc

Mar 26, 2021

05:18PM EDT Options Traders May Be Fearing More Downside For Cathie Wood's ARKK Benzinga

08:33AM EDT Cathie Wood Cautions Investors Against Transacting With Bitcoin Until Tax Code Is Changed Benzinga

Feb 26, 2021

02:00AM EST Tiziana Life Sciences Interview to Air on Bloomberg Television US GlobeNewswire Inc

Feb 18, 2021

07:00AM EST ASLAN Pharmaceuticals Appoints Dr Neil Graham as Independent Director GlobeNewswire Inc

Feb 16, 2021

10:02AM EST Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) ("Tiziana" or the "Company"),a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases,today announced that it is presenting at the BIO CEO & Investor Digital Conference, 16-18th February 2021. GlobeNewswire Inc

Feb 5, 2021

02:00AM EST Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces the appointment of Dr. Thomas Adams, Ph.D. as an executive director. GlobeNewswire Inc

Feb 3, 2021

02:00AM EST Tiziana Life Sciences plc (NASDAQ:TLSA/LSE:TILS) ("Tiziana" or the "Company"),a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases,today announced an interview with Dr. Kunwar Shailubhai, CEO and CSO, is now available. GlobeNewswire Inc

Feb 2, 2021

08:05AM EST The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment Benzinga

05:55AM EST Tiziana Life Sciences' Shares Rally As Foralumab Shows Encouraging Action In COVID-19 Study In Brazil Benzinga

02:00AM EST Tiziana Reports Positive Data from the Clinical Study of Nasal GlobeNewswire Inc

Jan 27, 2021

02:00AM EST Tiziana Life Sciences plc ("Tiziana" or the "Company") - Tiziana GlobeNewswire Inc

Jan 20, 2021

06:32AM EST Tiziana Life Sciences to Participate in a Fireside Chat at B. GlobeNewswire Inc

02:00AM EST Tiziana Life Sciences plc("Tiziana" or the "Company") GlobeNewswire Inc

Jan 13, 2021

11:58AM EST Tiziana Earlier Announced The Appointment Of Dr Neil Graham Mbbs, Md, Mph As Chief Medical Officer Benzinga

10:22AM EST Shares of Tiziana Life Sciences PLC (TLSA) are gaining over 25% on Wednesday morning. The biotechnology company announces the appointment of Dr Neil Graham as Chief Medical Officer. RTTNews

02:34AM EST Tiziana Life Sciences Appoints Neil Graham Chief Medical Officer RTTNews

02:00AM EST Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (Tiziana or the Company), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer. GlobeNewswire Inc

Jan 11, 2021

12:12PM EST Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS) ("Tiziana" or the "Company"),a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases,today announced that it is participating in the J.P. Morgan 39th Annual Healthcare Conference 2021. GlobeNewswire Inc

09:48AM EST Tiziana Life Sciences to Present at Biotech Showcase Digital 2021 GlobeNewswire Inc

Jan 4, 2021

06:21AM EST Tiziana Life Sciences Announced Completion of Clinical Trial with its Anti-CD3 Monoclonal Antibody for Treatment of COVID-19 Patients in Brazil Benzinga

02:00AM EST Tiziana Life Sciences plc ("Tiziana" or the "Company") - Tiziana GlobeNewswire Inc

Dec 18, 2020

06:38AM EST Tiziana Life Sciences PLC GlobeNewswire Inc

Dec 17, 2020

10:06AM EST Tiziana Life Sciences Received Notification Of Proposed Admission To Main Market Of London Stock Exchange, Cancellation Of Trading On AIM Market Benzinga

10:04AM EST Tiziana Life Sciences GlobeNewswire Inc

Dec 1, 2020

02:00AM EST Tiziana Life Sciences to Host Investor Update Call on 2 December GlobeNewswire Inc

Nov 18, 2020

10:16AM EST Tiziana Life Sciences PLC("Tiziana" or the "Company") GlobeNewswire Inc

Nov 11, 2020

05:43AM EST Tiziana Life Sciences Announced Collaboration With Parexel Biotech to Conduct Phase 1b/2 Clinical Trial in Patients With Crohn's Disease Benzinga

02:00AM EST First Ever Study with take-home capsules of Foralumab, aFully HumanAnti-CD3 Monoclonal Antibody GlobeNewswire Inc

Nov 2, 2020

02:00AM EST -- Highly innovative first-in-class study for treating COVID-19 disease with nasally administered drug -- Trial facilitated with collaboration of Harvard Medical School and one of the worlds top Neurologist, Dr. Howard Weiner -- Patent for potentially revolutionary nasally administered delivery system already filed -- Clinical Data Expected by End of Year GlobeNewswire Inc

Oct 27, 2020

12:01PM EDT Tiziana Life Sciences Announces Timetable of Demerger Of Accustem; Announces Completion Of Demerger Oct. 30, Record Date For Holders Of ADRs Nov. 6 Benzinga

12:00PM EDT Tiziana Life Sciences Announces Timetable of Demerger of GlobeNewswire Inc

Oct 2, 2020

07:00AM EDT At the General Meeting of the Company(Nasdaq: TLSA / AIM: TILS) held at 11.00 a.m. on 2 October 2020, both of the resolutions were duly passed. GlobeNewswire Inc

Sep 25, 2020

02:00AM EDT Tiziana Life Sciences Interview to Air on Bloomberg International GlobeNewswire Inc

Sep 21, 2020

10:06AM EDT HC Wainwright & Co. Maintains Buy on Tiziana Life Sciences, Lowers Price Target to $11 Benzinga

09:51AM EDT Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), is pleased to note the publication of a new analyst research note from H C Wainwright & Co which is available on the Companys website at https://ir.tizianalifesciences.com/static-files/0bae55ef-6589-43f2-a4bd-65be16b3dce1 GlobeNewswire Inc

Sep 17, 2020

02:00AM EDT Nasal Administration of Foralumab is a potentially transformative approach for treating patients with Covid-19 GlobeNewswire Inc

Sep 16, 2020

06:01AM EDT Tiziana Life Sciences Announces Planned Spin Out of StemPrintER into a New Publicly Listed Company, Accustem Sciences Benzinga

06:00AM EDT Tiziana Life Sciences Announces Planned Spin Out of StemPrintER GlobeNewswire Inc

05:50AM EDT Tiziana Life Sciences Announces Demerger of StemPrintER and Distribution in Specie Benzinga

02:00AM EDT Tiziana Life Sciences Plc("Tiziana" or the "Company") GlobeNewswire Inc

Aug 27, 2020

02:00AM EDT Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (Tiziana or the Company), a clinical stage biotechnology company developing targeted drugs for cancer, inflammatory diseases and COVID-19, today announced that an interview with its CEO and CSO Dr. Kunwar Shailubhai is now available. GlobeNewswire Inc

Aug 24, 2020

03:07AM EDT Tiziana Granted Patent On Methods And Use Of Anti-IL-6/IL-6 Receptor Monoclonal Antibodies RTTNews

02:00AM EDT Tiziana Granted a Patent on Methods and Use of Anti-IL-6/IL-6 GlobeNewswire Inc

Aug 21, 2020

06:07AM EDT Tiziana Earlier Announced it was Granted a Patent on the Use of Milciclib in Combination with Tyrosine Kinase Inhibitors for Treatment of Hepatocellular Carcinoma and other Cancers Benzinga

02:00AM EDT Tiziana Granted a Patent on the Use of Milciclib in Combination GlobeNewswire Inc

Aug 20, 2020

02:00AM EDT - Dr. Ferrara is the discoverer of Avastin and Lucentis, multi-billion dollars antibody drugs from Genentech GlobeNewswire Inc

Aug 18, 2020

05:36AM EDT Tiziana Granted U.S. Patent on Methods and Use of Anti-CD3 Monoclonal Antibodies for Treatment of Crohn's Disease Benzinga

02:00AM EDT Tiziana Granted a Patent on Methods and Use of Anti-CD3 Monoclonal GlobeNewswire Inc

Aug 11, 2020

04:00AM EDT Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (Tiziana or the Company), a clinical stage biotechnology company developing targeted drugs for cancer, inflammatory diseases and COVID-19, announced that members of its management team will participate virtually in the BTIG Biotechnology Conference onTuesday, August 11, 2020at2:30 p.m. EDT. GlobeNewswire Inc

Aug 5, 2020

11:00AM EDT Tiziana Life Sciences plcAnnounces Closing of $57.25 GlobeNewswire Inc

Aug 4, 2020

12:01PM EDT Tiziana Life Sciences shares are trading higher after the company announced an expedited clinical development plan for TZLS-501 for the treatment of COVID-19 patients. Benzinga

05:55AM EDT Tiziana Life Sciences Announces an Expedited Clinical Development Plan for Its Anti-Interleukin-6-Receptor, a Fully Human Monoclonal Antibody, for the Treatment of COVID-19 Patients Benzinga

02:00AM EDT -- Recently signed agreements with four contract research organizations (CROs) to initiate GMP manufacturing, develop inhalation technology, conduct inhalation safety toxicity study in monkeys, and initiate a human clinical trial in COVID-19 patients GlobeNewswire Inc

Aug 3, 2020

02:35PM EDT Mid-Afternoon Market Update: Dow Surges 260 Points; Varian Medical Systems Shares Climb Benzinga

12:06PM EDT Mid-Day Market Update: Crude Oil Rises 2%; ADT Shares Spike Higher Benzinga

10:14AM EDT Mid-Morning Market Update: Markets Open Higher; Tyson Foods Earnings Top Expectations Benzinga

09:54AM EDT Morning Market Stats in 5 Minutes Benzinga

05:38AM EDT Tiziana Life Science Prices 11M ADS Registered Direct Offering at $5.20/ADS Benzinga

02:00AM EDT Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs GlobeNewswire Inc

Jul 31, 2020

02:36PM EDT Mid-Afternoon Market Update: Dow Falls 175 Points; Pinterest Shares Climb Following Strong Results Benzinga

12:40PM EDT Mid-Day Market Update: Gold Surges 2.5%; Tiziana Life Sciences Shares Spike Higher Benzinga

12:05PM EDT Why Tiziana Life Sciences' Stock Is Trading Higher Today Benzinga

12:00PM EDT Tiziana Life Sciences plc(Nasdaq: TLSA / AIM: TILS) (the "Company" or "Tiziana"), a US andUKbiotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, today updated its total voting rights disclosure position. GlobeNewswire Inc

10:13AM EDT Mid-Morning Market Update: Markets Mixed; Apple Beats Q3 Expectations Benzinga

09:49AM EDT Morning Market Stats in 5 Minutes Benzinga

05:30AM EDT Tiziana Life Sciences Announces Submission of Patent Application for Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, for Treatment of COVID-19 Patients Benzinga

02:00AM EDT Tiziana Life Sciences plc: Tiziana Announces Submission of a GlobeNewswire Inc

Jul 30, 2020

11:35AM EDT Tiziana Life Sciences Gives Early Notification Of Proposed Admission To The Official List And Cancellation Of Trading On London Stock Exchange's AIM Benzinga

11:32AM EDT Tiziana Life Sciences plc: Early notification of proposed GlobeNewswire Inc

02:00AM EDT Tiziana Life Sciences to Participate in Investor Webinar to GlobeNewswire Inc

Jul 24, 2020

02:00AM EDT Exercise of Warrants andIssue of Equity and Total GlobeNewswire Inc

Jul 20, 2020

10:18AM EDT Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a US and UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, is pleased to announce the appointment of Mr. John Brancaccio to its Board as a Non-executive Director. GlobeNewswire Inc

Jul 17, 2020

05:08AM EDT 64 Biggest Movers From Yesterday Benzinga

Jul 16, 2020

07:24AM EDT Results of Annual General Meeting GlobeNewswire Inc

05:54AM EDT Tiziana Announces Submission of Patent Application on Use of Foralumab, the Only Fully Human Anti-CD3 Monoclonal Antibody, to Enhance Success of CAR-T Therapy Benzinga

02:00AM EDT Tiziana Announces Submission of Patent Application on Use of GlobeNewswire Inc

Jul 15, 2020

11:56AM EDT Tiziana Life Sciences plc("Tiziana", AIM: TILS, NASDAQ: TLSA), announces a ratio change to its sponsored Level 3 American Depositary Receipt ("ADR") programme. GlobeNewswire Inc

.dark-mode .sJ86Ld{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .sJ86Ld{ color: #333333; background-color: white; border: 2px solid #333333; }TLSATiziana Life Sciences Ltd. Common Sharesstock NASDAQ

TLSA
Tiziana Life Sciences Ltd. Common Shares
stock NASDAQ